Allarity Therapeutics, Inc. (ALLR)
Nasdaq: ALLR · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2021
Who owns Allarity Therapeutics, Inc.
As filed with the SECHolders of 5% or more
1
Olmsted Investments LLC holds 28.6% of Series A Convertible Redeemable Preferred Stock, as its SCHEDULE 13G filed Aug 29, 2024 says.
Directors and officers
5
report now, of 18 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Olmsted Investments LLC
SCHEDULE 13G · filed Aug 29, 2024 · Series A Convertible Redeemable Preferred Stock
What ALLR reports owning in othersstakes of 5% or more, and other ties
5 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 8, 2024.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 9, 2025 to Oct 9, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.